EUVIMEDEUVIMED entdecken
Open Access

Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma

Lei Cao, Jian Zhong, Zicheng Liu, Jie Jiang, Chenyao Zhu, Feng Liu, Bo Wang

Journal of Thoracic Disease · 2024-01 · 16 (1) · 581-592

DOI: 10.21037/jtd-23-1848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2024-01. Verfasst von Lei Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Nanjing Chest Hospital, Affiliated Nanjing Brain Hospital Nanjing Medical University, Nanjing, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The lysyl oxidate-like (LOXL) family was reported to be involved in the process of cancer development. However, the prognostic value of LOXL in lung cancer is unknown. We aimed to study the expression pattern and prognostic value of LOXL family members in lung squamous cell carcinoma (LUSC).

Methods

The Wilcoxon test and logistic regression analysis were used to study the expression level of LOXLs and its correlation with clinical characteristics. The Kaplan-Meier method and Cox regression analysis were performed to estimate the correlation of LOXsL expression with the survival of LUSC patients. Receiver operator characteristic (ROC) curves were plotted, and areas under the curves (AUCs) were calculated to estimate the diagnostic and prognostic power of LOXL. Cell Counting Kit-8 (CCK-8) assays, wound healing assays and Transwell assays were used to estimate the impact of LOXL2 on LUSC cells.

Results

LOXL1 and LOXL2 expression was upregulated in LUSC tissues (P

Schlagwörter

Stichwörter der Autor:innen

Lysyl oxidase-like proteinbiomarkerlung squamous cell carcinoma (LUSC)lysyl oxidase-like protein 2 (LOXL2)

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Nanjing Chest Hospital, Affiliated Nanjing Brain Hospital Nanjing Medical University, Nanjing, China.
  • Shenzhen Yuce Biotechnology Co., Ltd., Shenzhen, China.

Zitieren

APA

Cao, L., Zhong, J., Liu, Z., Jiang, J., Zhu, C., Liu, F., & Wang, B. (2024). Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma. Journal of Thoracic Disease, 16(1), 581-592. https://doi.org/10.21037/jtd-23-1848

Vancouver

Cao L, Zhong J, Liu Z, Jiang J, Zhu C, Liu F, et al. Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma. Journal of Thoracic Disease. 2024;16(1):581-592. doi:10.21037/jtd-23-1848

BibTeX
@article{Cao2024,
  author = {Cao, Lei and Zhong, Jian and Liu, Zicheng and Jiang, Jie and Zhu, Chenyao and Liu, Feng and Wang, Bo},
  title = {Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma},
  journal = {Journal of Thoracic Disease},
  year = {2024},
  volume = {16},
  number = {1},
  pages = {581--592},
  doi = {10.21037/jtd-23-1848}
}
Kostenlos starten →